ChemicalBook >> CAS DataBase List >>MLN9708

MLN9708

CAS No.
1201902-80-8
Chemical Name:
MLN9708
Synonyms
MLN9708;CS-1830;Ninlaro);MLN-9708 analog;MLN 9708 analog;MLN9708;MLN-9708;Ixazomib Citrate;Esazomide citrate;MLN9708,MLN-9708,MLN 9708;MLN 9708 - Ixazomib citrate
CBNumber:
CB82521079
Molecular Formula:
C20H23BCl2N2O9
Molecular Weight:
517.12
MDL Number:
MFCD18251437
MOL File:
1201902-80-8.mol
MSDS File:
SDS
Last updated:2023-06-08 09:02:27

MLN9708 Properties

Melting point >227°C (dec.)
Density 1.47
storage temp. Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly, Heated, Sonicated)
pka 1.92±0.20(Predicted)
form Solid
color White to Off-White
NCI Dictionary of Cancer Terms ixazomib citrate
FDA UNII E8R04MBQ04
NCI Drug Dictionary ixazomib citrate

Pharmacokinetic data

Protein binding 99%
Excreted unchanged in urine <3.5%
Volume of distribution 543 Litres
Biological half-life 9.5 days

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
Safety Statements  24/25
HS Code  29329990
NFPA 704
0
2 0

MLN9708 price More Price(19)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 18386 MLN9708 ≥95% 1201902-80-8 5mg $60 2024-03-01 Buy
Cayman Chemical 18386 MLN9708 ≥95% 1201902-80-8 1mg $43 2023-06-20 Buy
Cayman Chemical 18386 MLN9708 ≥95% 1201902-80-8 10mg $89 2024-03-01 Buy
Cayman Chemical 18386 MLN9708 ≥95% 1201902-80-8 50mg $208 2024-03-01 Buy
TRC M425158 MLN-9708 1201902-80-8 50mg $180 2021-12-16 Buy
Product number Packaging Price Buy
18386 5mg $60 Buy
18386 1mg $43 Buy
18386 10mg $89 Buy
18386 50mg $208 Buy
M425158 50mg $180 Buy

MLN9708 Chemical Properties,Uses,Production

Description

Ixazomib citrate is a proteasome inhibitor prodrug for the treatment of multiple myeloma in patients who have received at least one prior therapy in combination with lenalidomide and dexamethasone. The drug was developed by Takeda and reversibly inhibits the protein proteasome subunit β type-5, which is part of the 20S proteasome complex. Ixazomib citrate (XXIV) is hydrolyzed quickly in vivo to give the biologically active compound ixazomib, which presumably is the corresponding boronic acid variant of XXIV.

Uses

MLN-9708 is a novel proteasome?inhibitor.

Clinical Use

Highly selective and reversible proteasome inhibitor:
Treatment of multiple myeloma in combination with lenalidomide and dexamethasone

Synthesis

The structure of ixazomib citrate is particularly interesting in that it is one of the relatively few marketed drugs which feature a boron atom within its structure (others of note being the oncology medication bortezomib and the antifungal drug tavaborole13). The ostensible scale synthetic approach began with reaction of commercial 2,5-dichlorobenzoyl chloride (188) with glycine in aqueous NaOH to furnish amide 189 in 97% yield as a white crystalline solid. Acid 189 was then coupled with commercially available 1,3,2-benzodioxaborolane 190 in the presence of TBTU and DIPEA in DMF at low temperature to give diamide 191, which was used without purification for the next step. Borane 191 was then deprotected with (2-methylpropyl)boronic acid in methanolic HCl to provide trimer 192 in 74% as a white solid. Finally, boroxin 192 was reacted with citric acid in EtOAc to dissociate the trimer, resulting in ixazomib citrate (XXIV) in 88% yield as a crystalline solid.

Synthesis_1201902-80-8

MLN9708 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 178)Suppliers
Supplier Tel Email Country ProdList Advantage
Alpha Biopharmaceuticals Co., Ltd
+86-411-39042497 +8613921981412 sales@alphabiopharm.com China 886 58
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Lianyungang happen teng technology co., LTD
15950718863 wang666xt@163.com CHINA 295 58
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
AFINE CHEMICALS LIMITED
0571-85134551 info@afinechem.com CHINA 15377 58

View Lastest Price from MLN9708 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
MLN9708 pictures 2019-07-06 MLN9708
1201902-80-8
US $1.00 / kg 1kg 95%-99% 100kg Career Henan Chemical Co
  • MLN9708 pictures
  • MLN9708
    1201902-80-8
  • US $1.00 / kg
  • 95%-99%
  • Career Henan Chemical Co

MLN9708 Spectrum

4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid MLN9708 MLN9708,MLN-9708,MLN 9708 4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid 4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid MLN9708 Ixazomib Citrate MLN9708;MLN-9708 4-(Carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dio MLN 9708 analog MLN-9708 analog 4-(carboxymethyl)-2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid MLN 9708 - Ixazomib citrate CS-1830 MLN9708, 98%, 20S proteasome inhibitor 1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo- Ninlaro) Esazomide citrate Ixazomib Citrate (MLN9708) Analogue 1201902-80-8 C20H23BCl2N2O9 Inhibitors Inhibitor Apis